TrianglePUBLICATIONS · 24356636
Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II-IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2014 Jan
- First author
- Harano K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Harano K
- type
- Author
- name
- Terauchi F
- type
- Author
- name
- Katsumata N
- type
- Author
- name
- Takahashi F
- type
- Author
- name
- Yasuda M
- type
- Author
- name
- Takakura S
- type
- Author
- name
- Takano M
- type
- Author
- name
- Yamamoto Y
- type
- Author
- name
- Sugiyama T
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Harano K
- type
- Author
- name
- Terauchi F
- type
- Author
- name
- Katsumata N
- type
- Author
- name
- Takahashi F
- type
- Author
- name
- Yasuda M
- type
- Author
- name
- Takakura S
- type
- Author
- name
- Takano M
- type
- Author
- name
- Yamamoto Y
- type
- Author
- name
- Sugiyama T
- type
- Author
- bibliography ids
- nci-bib-00f6a6c1a2dba671dac8e66b
- book metadata
- content sha256
- 6fdddc207bed7bcdf08646f99964f155816bfea4d68b3e688611a6dc76c86895
- document type
- citation
- dois
- 10.1093/annonc/mdt527
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24356636
- immutable id
- pubmed:24356636@6fdddc207bed7bcdf08646f99964f155816bfea4d68b3e688611a6dc76c86895
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 1
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 251-7
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24356636
- provenance
- batch id
- af10498814d931b53231
- provider
- NCBI PubMed ESummary
- record sha256
- c0bd86692090e239e9b14871e7b476c2ea8075e428e5141ede96da3fc31bbc4d
- response sha256
- 077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
- retrieved at
- 2026-09-09T23:47:00.193465+00:00
- publication date
- display
- 2014 Jan
- precision
- month
- year
- 2014
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II-IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016).
Preserved source evidence · Not medical advice